Maizel Ari (CIK 2042289) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-23). Recent activity: Buy AXSM (7,500 shares), Sell AXSM (7,500 shares), Buy AXSM (7,500 shares), Sell AXSM (7,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-23 | Axsome Therapeutics, Inc. (AXSM) | Chief Commercial Officer | Buy | 7,500 | $530,475 |
| 2026-04-23 | Axsome Therapeutics, Inc. (AXSM) | Chief Commercial Officer | Sell | 7,500 | $1.4M |
| 2026-01-23 | Axsome Therapeutics, Inc. (AXSM) | Chief Commercial Officer | Buy | 7,500 | $530,475 |
| 2026-01-23 | Axsome Therapeutics, Inc. (AXSM) | Chief Commercial Officer | Sell | 7,500 | $1.4M |
Source: SEC Form 4 filings · as of 2026-04-23